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Abstract
Background: The uterine cervix has the ability to be transformed from being a rigid or-
gan in non-pregnant women to become a loose structure that dilates and allows passage of 
the foetus at parturition. This process, cervical ripening, has been described similar to an in-
flammatory reaction of the extracellular matrix involving activation of inflammatory cy-
tokines, matrix metalloproteinases and breakdown of the collagen framework. Cervical 
ripening can be induced prior to surgical termination of pregnancy by agents such as prostag-
landins (PGs) and nitric oxide (NO). It appears reasonable that cervical ripening takes place 
as a spontaneous event in women with miscarriage before expulsion of gestational products. 
Aims: The aims of the thesis were to investigate clinical, morphological and biochemi-
cal aspects of cervical ripening in the first trimester, both when induced by PGs or NO do-
nors and when spontaneously occurring in women with symptomatic and silent miscarriage.
Methods: Nulliparous women admitted for surgical termination of pregnancies in the first 
trimester were randomized to cervical priming with either gemeprost or misoprostol (Study 
I), and to misoprostol or isosorbide mononitrate (IMN) (Study II). In Study I and II, the ef-
ficacy of cervical priming was measured by tonometry. Side effects were also estimated. In 
Study III cervical biopsies from women treated with misoprostol or IMN were analyzed us-
ing electron microscopy (EM). Inflammatory parameters were analyzed by ELISA (IL-
8) and immunohistochemistry (IHC) (MMP-1, MMP-9). In Study IV biopsies were ob-
tained from nulliparous women suffering symptomatic or silent miscarriage and from 
women undergoing surgical termination of pregnancy. Morphology was studied by EM 
and inflammatory parameters by ELISA (IL-8) and IHC (IL-8, MMP-1, MMP-8, MMP-9).
Results: There was no difference in baseline cervical dilation and cumulative force to dilate the 
cervix to 10 mm in women treated with misoprostol compared to gemeprost. Cervical resist-
ance was higher in women treated with IMN compared to women treated with misoprostol. 
Abdominal pain and vaginal bleeding were frequent following cervical priming with misopr-
ostol, while headache was common following IMN. In cervical specimens from women treated 
with misoprostol the collagen framework was disorganized and fibroblasts and mast cells ap-
peared activated. Similar ultrastructural changes were observed in specimens from women treat-
ed with IMN, though less pronounced. Cervical tissue levels of IL-8 were higher in women 
treated with misoprostol compared to IMN and controls. Immunohistochemical staining for 
MMP-1 and MMP-9 was of higher intensity in women treated with IMN compared to miso-
prostol. In cervical tissue from women with miscarriage the organization of the collagen frame-
work was deranged. Fibroblasts were reactive and mast cells were frequently observed and dem-
onstrated secretory activity. Tissue levels of IL-8 were increased in women with miscarriage. 
Immunopositivity of MMP-1 and MMP-8 did not differ between women with miscarriage 
and control women. MMP-9 was lower in women with symptomatic miscarriage compared to 
women with silent miscarriage and controls. Conclusions: Misoprostol is as effective as geme-
prost for cervical priming in the first trimester. Misoprostol induces a more pronounced cer-
vical ripening than IMN, but both treatments are associated with side effects when the treat-
ment interval exceeds 4 hours. Both misoprostol and IMN induces a tissue response consistent 
with an inflammatory reaction. In women suffering either symptomatic or silent miscarriage 
an inflammatory response takes place, indicating an ongoing ripening process. Therefore, inad-
equate cervical remodelling does not seem to be the reason why some miscarriages remain silent. 
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